Loading, please wait ...


News Analytics

9263d890 dcd4 460d 96a4 99b6f74b2581?size=1.
ALLSCHWIL, Switzerland, June 08, 2021 (GLOBE NEWSWIRE) -- Polyphor AG (SIX: POLN) a research driven clinical stage, Swiss biopharmaceutical company committed to discovering and developing best-in-class molecules in oncology and antimicrobial resistance, today announced that it will host a key opinion leader (KOL) roundtable on Covid-19, the need for novel therapies for severe infections and the potential role of balixafortide, a selective ...
Google

Subject Matter

  • Science and technology 54.55%
  • Healthcare 45.45%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions